Observations with Paxirasol nasal spray therapy following open heart operations.
The effect of Paxirasol nasal spray (EGIS) has been examined in 25 patients following open heart surgery. In 18 of the patients increased secretion, in 7 crusting due to dryness of mucosa were observed as accompanying symptoms. These symptoms ceased in response to Paxirasol therapy, in the former cases within one week, in the latter ones within two weeks. The drug was applied in daily 3-5 times 1-mg (3-5 x 5 puffs) doses.
Tomcsányi
I
I
First Department of Surgery, Postgraduate Medical School, Budapest.
D000328:Adult; D000336:Aerosols; D000368:Aged; D001964:Bromhexine / Q000008:administration & dosage* / Q000494:pharmacology; D006348:Cardiac Surgical Procedures; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009079:Mucociliary Clearance / Q000187:drug effects; D015508:Nasal Obstruction / Q000188:drug therapy; D011182:Postoperative Care
D000336:Aerosols; D001964:Bromhexine